Patents by Inventor Jeroen De Buck

Jeroen De Buck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210116443
    Abstract: The present disclosure relates to a method referred to herein as the “split trehalase assay biosensor” (also referred to herein as “STIGA”) is based on the use of engineered E. coli trehalase to detect analytes such as antibodies in a sample. The trehalase is engineered in a way such that the enzyme is split into two inactive fragments (N-terminal fragment H and C-terminal fragment A) with antigens fused to both fragments. When bivalent antibodies react specifically with the fused antigens, two inactive trehalase fragments are brought together in close proximity to restore the activity of trehalase. The restored trehalase will hydrolyze trehalose into two glucose molecules that can be measured using existing glucose detection methods such as glucometer, Benedict's reagent, or ACCU-CHEK AVIVA® glucose test strips.
    Type: Application
    Filed: December 29, 2020
    Publication date: April 22, 2021
    Inventor: Jeroen De Buck
  • Patent number: 10900960
    Abstract: The present disclosure relates to a method referred to herein as the “split trehalase assay biosensor” (also referred to herein as “STIGA”) is based on the use of engineered E. coli trehalase to detect analytes such as antibodies in a sample. The trehalase is engineered in a way such that the enzyme is split into two inactive fragments (N-terminal fragment H and C-terminal fragment A) with antigens fused to both fragments. When bivalent antibodies react specifically with the fused antigens, two inactive trehalase fragments are brought in close proximity to restore the activity of trehalase. The restored trehalase will hydrolyze trehalose into two glucose molecules which can be measured using existing glucose detection methods such as glucometer, Benedict's reagent, or ACCU-CHEK AVIVA® glucose test strips.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: January 26, 2021
    Assignee: Creative Protein Solutions Inc.
    Inventor: Jeroen De Buck
  • Publication number: 20190257824
    Abstract: The present disclosure relates to a method referred to herein as the “split trehalase assay biosensor” (also referred to herein as “STIGA”) is based on the use of engineered E. coli trehalase to detect analytes such as antibodies in a sample. The trehalase is engineered in a way such that the enzyme is split into two inactive fragments (N-terminal fragment H and C-terminal fragment A) with antigens fused to both fragments. When bivalent antibodies react specifically with the fused antigens, two inactive trehalase fragments are brought in close proximity to restore the activity of trehalase. The restored trehalase will hydrolyze trehalose into two glucose molecules which can be measured using existing glucose detection methods such as glucometer, Benedict's reagent, or ACCU-CHEK AVIVA® glucose test strips.
    Type: Application
    Filed: February 28, 2019
    Publication date: August 22, 2019
    Applicant: Creative Protein Solutions Inc.
    Inventor: Jeroen De Buck